BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10147288)

  • 1. Cost-effectiveness opportunities for new antibiotics.
    Hillman A
    Pharmacoeconomics; 1994; 5(Suppl 2):40-3. PubMed ID: 10147288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection.
    Quenzer RW; Pettit KG; Arnold RJ; Kaniecki DJ
    Am J Manag Care; 1997 Jul; 3(7):1027-36. PubMed ID: 10173367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managed care: has the revolution arrived?
    Lewis TS
    Med Device Technol; 1998 Mar; 9(2):42-8. PubMed ID: 10186977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomics of antibacterial treatment.
    Davey PG; Malek MM; Parker SE
    Pharmacoeconomics; 1992 Jun; 1(6):409-37. PubMed ID: 10147022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating quality of life data into managed care formulary decisions: a case study with salmeterol.
    Bukstein DA
    Am J Manag Care; 1997 Nov; 3(11):1701-6. PubMed ID: 10178468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. After managed care, what?
    Shore MF
    Harv Rev Psychiatry; 2000; 7(6):365-70. PubMed ID: 10749394
    [No Abstract]   [Full Text] [Related]  

  • 8. Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.
    Lipsy RJ
    Pharmacoeconomics; 1992 Apr; 1(4):265-81. PubMed ID: 10147017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of the cost and effectiveness of generic and brand-name antibiotics: the case of uncomplicated urinary tract infection.
    Lin YS; Jan IS; Cheng SH
    Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):301-309. PubMed ID: 27862588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of primary care in a managed care era.
    Starfield B
    Int J Health Serv; 1997; 27(4):687-96. PubMed ID: 9399113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of interventions in diabetes: a review of published economic evaluations in the UK setting, with an eye on the future.
    Tucker DM; Palmer AJ
    Prim Care Diabetes; 2011 Apr; 5(1):9-17. PubMed ID: 21071296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "Hillary effect" is actually effective managed care.
    Elden DL
    AAPPO J; 1994; 4(2):9, 39-40. PubMed ID: 10147202
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibiotic usage: pharmacoeconomic impact in a changing healthcare system.
    Milkovich G
    Drugs; 1996; 52 Suppl 2():80-2. PubMed ID: 8869842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, Medicaid and other US government payers perspectives: the ISPOR Drug Cost Task Force report--Part IV.
    Mullins CD; Seal B; Seoane-Vazquez E; Sankaranarayanan J; Asche CV; Jayadevappa R; Lee WC; Romanus DK; Wang J; Hay JW; Smeeding J
    Value Health; 2010; 13(1):18-24. PubMed ID: 19807903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care reforms and managed care for substance abuse services: findings from eleven case studies.
    French MT; Dunlap LJ; Galinis DN; Rachal JV; Zarkin GA
    J Public Health Policy; 1996; 17(2):181-203. PubMed ID: 8764391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons from Medicare+Choice for Medicare reform.
    Dallek G; Biles B; Hersch Nicholas L
    Policy Brief Commonw Fund; 2003 Jun; (658):1-17. PubMed ID: 12833910
    [No Abstract]   [Full Text] [Related]  

  • 17. Managed care or managed costs?
    Dyer AR
    Aust N Z J Psychiatry; 1996 Jun; 30(3):317-8. PubMed ID: 8839940
    [No Abstract]   [Full Text] [Related]  

  • 18. Economic aspects of antimicrobial therapy of acute exacerbations of COPD.
    Simoens S; Decramer M; Laekeman G
    Respir Med; 2007 Jan; 101(1):15-26. PubMed ID: 16650975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will there be a job for you? The physician work force under health care reform.
    Wartman SA
    Pharos Alpha Omega Alpha Honor Med Soc; 1995; 58(2):2-6. PubMed ID: 7784483
    [No Abstract]   [Full Text] [Related]  

  • 20. New systems: the restructuring of cancer care delivery and economics.
    Harvey C
    Oncol Nurs Forum; 1994; 21(1):72-7. PubMed ID: 8140005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.